
Waters Corporation
WATNYSEHealthcareMedical - Diagnostics & Research
Previous close
$410.7
+$6.01 · +1.49%
WAT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
41
Fair Value
Momentum
46
Neutral
Sentiment
70
Bullish
Risk resilience
69
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteWaters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Udit Batra
- Listed since
- Nov 17, 1995
- Employees
- 7,900
Market position
Day range
Current $410.7
52-week range
Current $410.7
- Open
- $400.5
- Previous close
- $404.69
- Volume
- 683.84K
- 0.7× average
- Average volume
- 977.47K
- Average daily volume
- Market cap
- 30.72B USD
- Beta
- 1.18
- Market reference 1
- 50-day average
- $381.24
- +7.73% above average
- 200-day average
- $358.96
- +14.41% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 23.51B USD
- P/E (TTM)
- 102.16×
- P/B (TTM)
- 2.65×
- P/S (TTM)
- 6.61×
- EV / EBITDA
- 23.23×
- Earnings yield
- 2.84%
- Free cash flow yield
- 2.39%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 50.78%
- Operating margin
- 7.96%
- Net margin
- 3.58%
- Return on equity
- 25.09%
- Return on assets
- 12.66%
- Return on invested capital
- 17.57%
Financial health
- Debt / equity
- 0.35×
- Current ratio
- 1.73×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.17B USD | 2.96B USD | 2.96B USD | 2.97B USD | 2.79B USD |
| Cost of goods sold | 1.34B USD | 1.2B USD | 1.2B USD | 1.25B USD | 1.16B USD |
| Gross profit | 1.83B USD | 1.76B USD | 1.76B USD | 1.72B USD | 1.63B USD |
| Research and development | 195.18M USD | 183.03M USD | 174.95M USD | 176.19M USD | 168.36M USD |
| Selling, general, and administrative | 740.27M USD | 690.15M USD | 736.01M USD | 658.03M USD | 626.97M USD |
| Operating expenses | 935.45M USD | 931.83M USD | 943.52M USD | 850.38M USD | 807.63M USD |
| Interest income | 7.39M USD | 17.42M USD | 16.62M USD | 11.02M USD | 12.22M USD |
| Interest expense | 69.55M USD | 89.68M USD | 98.86M USD | 48.8M USD | 44.94M USD |
| Depreciation and amortization | 206.24M USD | 191.83M USD | 165.91M USD | 130.42M USD | 131.68M USD |
| Operating income | 893.22M USD | 826.35M USD | 817.68M USD | 873.4M USD | 821.71M USD |
| Net income | 642.63M USD | 637.83M USD | 642.23M USD | 707.76M USD | 692.84M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$420.64
2.42% upsideRating distribution
36 ratingsCorporate actions
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Nov 26, 1996 | $0.16Irregular | — | — |
Ex-dividend Nov 26, 1996
$0.16
Irregular
WAT peers
ETFs holding WAT
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.18B0.05%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO972.85M0.06%1.7T USD0.03%$703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO801.76M0.36%224.7B USD0.03%$82.97+0.53%
iShares Core S&P 500 ETFIVV535.55M0.06%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY493.57M0.06%817.87B USD0.09%$765.72+0.41%
State Street Health Care Select Sector SPDR ETFXLV285.83M0.64%44.76B USD0.08%$174.62+1.29%
Vanguard Morningstar Mid-Cap Growth ETFVOT283.31M0.84%33.5B USD0.05%$305.46+0.79%
Vanguard Morningstar Growth ETFVUG261.27M0.07%372B USD0.03%$87.50+0.38%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.18B
- Weight
- 0.05%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 972.85M
- Weight
- 0.06%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 801.76M
- Weight
- 0.36%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
iShares Core S&P 500 ETFIVV- Market value
- 535.55M
- Weight
- 0.06%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 493.57M
- Weight
- 0.06%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 285.83M
- Weight
- 0.64%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Vanguard Morningstar Mid-Cap Growth ETFVOT- Market value
- 283.31M
- Weight
- 0.84%
- AUM
- 33.5B USD
- Expense ratio
- 0.05%
- Price / 1D
- $305.46+0.79%
Vanguard Morningstar Growth ETFVUG- Market value
- 261.27M
- Weight
- 0.07%
- AUM
- 372B USD
- Expense ratio
- 0.03%
- Price / 1D
- $87.50+0.38%
Continue in GoAI
Research WATresearch.disclaimer





